Alveolus Bio Secures Strategic Investment from Shilpa Medicare for Revolutionary Lung Therapies Alveolus Bio recently received a strategic investment from Shilpa Medicare, setting the stage for breakthrough lung disease treatments.

Alveolus Bio Secures Strategic Investment from Shilpa Medicare for Revolutionary Lung Therapies #USA #Birmingham #Shilpa_Medicare #Alveolus_Bio #Lung_Therapy